Cultures with Improved Phage Resistance

a technology of phages and cultures, applied in the field of cultures with improved phage resistance, can solve the problems of occupying a large space and equipment, phage contamination, and phage contamination, and achieve the effect of reducing the degree of homology to the spacer, reducing or decreasing

Inactive Publication Date: 2011-01-06
DUPONT NUTRITION BIOSCIENCES APS
View PDF11 Cites 166 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0019]The present invention also provides methods for modulating (e.g., reducing or decreasing) the resistance of a cell comprising at least one or more cas genes or proteins and two or more CRISPR repeats against a target nucleic acid or a transcription product thereof comprising the steps of: (i) identifying one or more CRISPR spacers in an organism that is substantially resistant to the target nucleic acid or transcription product thereof; and (ii) modifying the sequence of at least one or more CRISPR spacer(s) in the cell such that the CRISPR spacer(s) has a reduced degree of homology to the spacer(s) in the organism.
[0020]The present invention also provides methods for modulating (e.g., reducing or decreasing) the resistance of a cell comprising at least one or more cas genes or proteins and two or more CRISPR repeats against a target nucleic acid or a transcription product thereof comprising modifying the one or more cas genes or proteins and / or two or more CRISPR repeats in the cell.

Problems solved by technology

The preparation of cultures is labor intensive, occupying much space and equipment, and there is a considerable risk of contamination with spoilage bacteria and / or phages during the propagation steps.
The failure of bacterial cultures due to bacteriophage (phage) infection and multiplication is a major problem with the industrial use of bacterial cultures.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cultures with Improved Phage Resistance
  • Cultures with Improved Phage Resistance
  • Cultures with Improved Phage Resistance

Examples

Experimental program
Comparison scheme
Effect test

example 1

Manipulation of Phage-Specific Spacers

[0481]In this Example, experiments conducted to manipulate phage-specific spacers are described. In some experiments, a phage specific spacer was inserted into an existing, functional CRISPR to provide resistance to the corresponding phage are described. The bacterial strain used was Streptococcus thermophilus ST0089 and the phage was phage 2972. S. thermophilus ST0089 is an industrially important strain used in the manufacture of yogurt. It is genetically amenable to manipulation, and susceptible to the well-known virulent phage 2972.

[0482]The CRISPR loci were determined in strain ST0089. This was determined preferentially by sequencing the entire genome of ST0089. Alternatively, the CRISPR loci are identified via PCR using primer sets with sequences identical to S. thermophilus CRISPR elements previously identified.

[0483]Once identified, the CRISPR loci sequences were determined as well as the proximal regions containing the relevant cas genes...

example 2

Integration of CRISPR Spacer(s)

[0500]In these experiments, integration of a CRISPR spacer into the CRISPR locus was shown to provide resistance against a bacteriophage to which the CRISPR spacer shows identity. In these experiments, S. thermophilus strain DGCC7710RH1 was produced.

[0501]Streptococcus thermophilus strain DGCC7710 (deposited at the French “Collection Nationale de Cultures de Microorganismes” under number CNCM I-2423) possesses at least 3 CRISPR loci: CRISPR1, CRISPR2, and CRISPR3. In S. thermophilus strains CNRZ1066 and LMGI8311 for which the complete genome sequence is known (Bolotin et al., Microbiol., 151:2551-1561 [2005]. CRISPR1 is located at the same chromosomal locus: between str0660 (or stu0660) and str0661 (or stu0661).

[0502]In strain DGCC7710, CRISPR1 is also located at the same chromosomal locus, between highly similar genes. CRISPR1 of strain DGCC7710 contains 33 repeats (including the terminal repeat), and thus 32 spacers.

[0503]All these spacers are differ...

example 3

Construct Integration and Knockout

[0524]In this Example, methods used for construct integration and knockout are described.

[0525]The strains used in these experiments were:

S. thermophilus DGCC7710 parent strain, sensitive to phages 858 and 2972

S. thermophilus DGCC7778 CRISPR mutant resistant to 858

S. thermophilus DGCC7778cas1KO

S. thermophilus DGCC7778cas4KO

S. thermophilus DGCC7778RT

S. thermophilus DGCC7778RT′

S. thermophilus DGCC7710R2CRISPR mutant resistant to 2972

S. thermophilus DGCC7710R2S1S2

E. coli EC1,000 provided pOR128 (See, Russell and Klaenhammer, Appl. Environ. Microbiol., 67:43691-4364 [2001])

Escherichia coli pCR2.1TOPO provided pTOPO (See, Invitrogen catalog #K4500-01)

[0526]The following plasmids were used in these experiments:

pTOPO, a plasmid used for sub-cloning of the various constructs

pTOPOcas1ko contains an integral fragment of cas1

pTOPOcas4ko contains an integral fragment of cas4

pTOPOS1S2 contains the S1S2 spacer construct

pTOPO RT contains the RT terminal repeat con...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
or more nucleic acidaaaaaaaaaa
selective pressureaaaaaaaaaa
nucleic acidaaaaaaaaaa
Login to view more

Abstract

The present invention provides methods and compositions related to modulating the resistance of a cell against a target nucleic acid or a transcription product thereof. In some preferred embodiments, the present invention provides compositions and methods for the use of one or more cas genes or proteins for modulating the resistance of a cell against a target nucleic acid or a transcription product thereof. In some embodiments, the present invention provides methods and compositions that find use in the development and use of strain combinations and starter culture rotations. In additional embodiments, the present invention provides methods for labelling and/or identifying bacteria. In some preferred embodiments, the present invention provides methods for the use of CRISPR loci to determine the potential virulence of a phage against a cell and the use of CRISPR-cas to modulate the genetic sequence of a phage for increased virulence level. In still further embodiments, the present invention provides means and compositions for the development and use of phages as biocontrol agents.

Description

FIELD OF THE INVENTION[0001]The present invention provides methods and compositions related to modulating the resistance of a cell against a target nucleic acid or a transcription product thereof. In some preferred embodiments, the present invention provides compositions and methods for the use of one or more cas genes or proteins for modulating the resistance of a cell against a target nucleic acid or a transcription product thereof. In some embodiments, the present invention provides methods and compositions that find use in the development and use of strain combinations and starter culture rotations. In additional embodiments, the present invention provides methods for labelling and / or identifying bacteria. In some preferred embodiments, the present invention provides methods for the use of CRISPR loci to determine the potential virulence of a phage against a cell and the use of CRISPR-cas to modulate the genetic sequence of a phage for increased virulence level. In still further...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K35/74C12N15/74C12N1/21A23L1/00A23C9/12A23K20/195
CPCA23C9/123A23C9/1238A23C2220/202C12N1/20C12N15/746C12Q1/70C12N2795/00011A23Y2240/75C12Q2525/151A23V2400/249
Inventor BARRANGOU, RODOLPHEFREMAUX, CHRISTOPHEHORVATH, PHILIPPEROMERO, DENNISBOYAVAL, PATRICK
Owner DUPONT NUTRITION BIOSCIENCES APS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap